 | • レポートコード：MRC2-11QY01754 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はインスリン薬・デリバリー技術のグローバル市場について調査・分析したレポートです。種類別（インスリン注射器、インスリンバイアル、インスリンペン、インスリンポンプ）市場規模、用途別（1型糖尿病、2型糖尿病、妊娠糖尿病）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別インスリン薬・デリバリー技術の競争状況、市場シェア ・世界のインスリン薬・デリバリー技術市場：種類別市場規模 2015年-2020年（インスリン注射器、インスリンバイアル、インスリンペン、インスリンポンプ） ・世界のインスリン薬・デリバリー技術市場：種類別市場規模予測 2021年-2026年（インスリン注射器、インスリンバイアル、インスリンペン、インスリンポンプ） ・世界のインスリン薬・デリバリー技術市場：用途別市場規模 2015年-2020年（1型糖尿病、2型糖尿病、妊娠糖尿病） ・世界のインスリン薬・デリバリー技術市場：用途別市場規模予測 2021年-2026年（1型糖尿病、2型糖尿病、妊娠糖尿病） ・北米のインスリン薬・デリバリー技術市場分析：米国、カナダ ・ヨーロッパのインスリン薬・デリバリー技術市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのインスリン薬・デリバリー技術市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のインスリン薬・デリバリー技術市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのインスリン薬・デリバリー技術市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi、Eli Lilly and Company、Biocon、Julphar、Ypsomed、Becton, Dickinson and Company ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along with glucose to treat high blood potassium levels. Typically it is given by injection under the skin, but some forms may also be used by injection into a vein or muscle.
The emerging technologies in the insulin drug and delivery field have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods. Modern industries and research institutes have begun to explore newer method for diabetes control in adults and juveniles, leading to a steady market for these technologies. Research and development (R&D) spending, increasing competition, patent expiries and emerging technologies are guiding this to a new direction. The new advancements, new product launches, and increased awareness and early detection of the disease have influenced the market to grow in the foreseeable future.
Market Analysis and Insights: Global Insulin Drug and Delivery Technologies Market
The global Insulin Drug and Delivery Technologies market size is projected to reach US$ 36000 million by 2026, from US$ 32570 million in 2020, at a CAGR of 9.4%% during 2021-2026.
Global Insulin Drug and Delivery Technologies Scope and Market Size
Insulin Drug and Delivery Technologies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Insulin Drug and Delivery Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Insulin Drug and Delivery Technologies market is segmented into
Insulin Syringes
Insulin Vials
Insulin Pens
Insulin Pumps
Segment by Application, the Insulin Drug and Delivery Technologies market is segmented into
Diabetes Mellitus Type 1
Diabetes Mellitus Type 2
Gestational Diabetes
Regional and Country-level Analysis
The Insulin Drug and Delivery Technologies market is analysed and market size information is provided by regions (countries).
The key regions covered in the Insulin Drug and Delivery Technologies market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Insulin Drug and Delivery Technologies Market Share Analysis
Insulin Drug and Delivery Technologies market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Insulin Drug and Delivery Technologies business, the date to enter into the Insulin Drug and Delivery Technologies market, Insulin Drug and Delivery Technologies product introduction, recent developments, etc.
The major vendors covered:
Sanofi
Eli Lilly and Company
Biocon
Julphar
Ypsomed
Becton, Dickinson and Company
…
1 Study Coverage
1.1 Insulin Drug and Delivery Technologies Product Introduction
1.2 Market Segments
1.3 Key Insulin Drug and Delivery Technologies Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Insulin Drug and Delivery Technologies Market Size Growth Rate by Type
1.4.2 Insulin Syringes
1.4.3 Insulin Vials
1.4.4 Insulin Pens
1.4.5 Insulin Pumps
1.5 Market by Application
1.5.1 Global Insulin Drug and Delivery Technologies Market Size Growth Rate by Application
1.5.2 Diabetes Mellitus Type 1
1.5.3 Diabetes Mellitus Type 2
1.5.4 Gestational Diabetes
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Insulin Drug and Delivery Technologies Market Size, Estimates and Forecasts
2.1.1 Global Insulin Drug and Delivery Technologies Revenue 2015-2026
2.1.2 Global Insulin Drug and Delivery Technologies Sales 2015-2026
2.2 Global Insulin Drug and Delivery Technologies, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Insulin Drug and Delivery Technologies Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Insulin Drug and Delivery Technologies Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Insulin Drug and Delivery Technologies Competitor Landscape by Players
3.1 Insulin Drug and Delivery Technologies Sales by Manufacturers
3.1.1 Insulin Drug and Delivery Technologies Sales by Manufacturers (2015-2020)
3.1.2 Insulin Drug and Delivery Technologies Sales Market Share by Manufacturers (2015-2020)
3.2 Insulin Drug and Delivery Technologies Revenue by Manufacturers
3.2.1 Insulin Drug and Delivery Technologies Revenue by Manufacturers (2015-2020)
3.2.2 Insulin Drug and Delivery Technologies Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Insulin Drug and Delivery Technologies Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Insulin Drug and Delivery Technologies Revenue in 2019
3.2.5 Global Insulin Drug and Delivery Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Insulin Drug and Delivery Technologies Price by Manufacturers
3.4 Insulin Drug and Delivery Technologies Manufacturing Base Distribution, Product Types
3.4.1 Insulin Drug and Delivery Technologies Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Insulin Drug and Delivery Technologies Product Type
3.4.3 Date of International Manufacturers Enter into Insulin Drug and Delivery Technologies Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Insulin Drug and Delivery Technologies Market Size by Type (2015-2020)
4.1.1 Global Insulin Drug and Delivery Technologies Sales by Type (2015-2020)
4.1.2 Global Insulin Drug and Delivery Technologies Revenue by Type (2015-2020)
4.1.3 Insulin Drug and Delivery Technologies Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Insulin Drug and Delivery Technologies Market Size Forecast by Type (2021-2026)
4.2.1 Global Insulin Drug and Delivery Technologies Sales Forecast by Type (2021-2026)
4.2.2 Global Insulin Drug and Delivery Technologies Revenue Forecast by Type (2021-2026)
4.2.3 Insulin Drug and Delivery Technologies Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Insulin Drug and Delivery Technologies Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Insulin Drug and Delivery Technologies Market Size by Application (2015-2020)
5.1.1 Global Insulin Drug and Delivery Technologies Sales by Application (2015-2020)
5.1.2 Global Insulin Drug and Delivery Technologies Revenue by Application (2015-2020)
5.1.3 Insulin Drug and Delivery Technologies Price by Application (2015-2020)
5.2 Insulin Drug and Delivery Technologies Market Size Forecast by Application (2021-2026)
5.2.1 Global Insulin Drug and Delivery Technologies Sales Forecast by Application (2021-2026)
5.2.2 Global Insulin Drug and Delivery Technologies Revenue Forecast by Application (2021-2026)
5.2.3 Global Insulin Drug and Delivery Technologies Price Forecast by Application (2021-2026)
6 North America
6.1 North America Insulin Drug and Delivery Technologies by Country
6.1.1 North America Insulin Drug and Delivery Technologies Sales by Country
6.1.2 North America Insulin Drug and Delivery Technologies Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Insulin Drug and Delivery Technologies Market Facts & Figures by Type
6.3 North America Insulin Drug and Delivery Technologies Market Facts & Figures by Application
7 Europe
7.1 Europe Insulin Drug and Delivery Technologies by Country
7.1.1 Europe Insulin Drug and Delivery Technologies Sales by Country
7.1.2 Europe Insulin Drug and Delivery Technologies Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Insulin Drug and Delivery Technologies Market Facts & Figures by Type
7.3 Europe Insulin Drug and Delivery Technologies Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Insulin Drug and Delivery Technologies by Region
8.1.1 Asia Pacific Insulin Drug and Delivery Technologies Sales by Region
8.1.2 Asia Pacific Insulin Drug and Delivery Technologies Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Insulin Drug and Delivery Technologies Market Facts & Figures by Type
8.3 Asia Pacific Insulin Drug and Delivery Technologies Market Facts & Figures by Application
9 Latin America
9.1 Latin America Insulin Drug and Delivery Technologies by Country
9.1.1 Latin America Insulin Drug and Delivery Technologies Sales by Country
9.1.2 Latin America Insulin Drug and Delivery Technologies Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Insulin Drug and Delivery Technologies Market Facts & Figures by Type
9.3 Central & South America Insulin Drug and Delivery Technologies Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Insulin Drug and Delivery Technologies by Country
10.1.1 Middle East and Africa Insulin Drug and Delivery Technologies Sales by Country
10.1.2 Middle East and Africa Insulin Drug and Delivery Technologies Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Insulin Drug and Delivery Technologies Market Facts & Figures by Type
10.3 Middle East and Africa Insulin Drug and Delivery Technologies Market Facts & Figures by Application
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Insulin Drug and Delivery Technologies Products Offered
11.1.5 Sanofi Related Developments
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Corporation Information
11.2.2 Eli Lilly and Company Description and Business Overview
11.2.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Eli Lilly and Company Insulin Drug and Delivery Technologies Products Offered
11.2.5 Eli Lilly and Company Related Developments
11.3 Biocon
11.3.1 Biocon Corporation Information
11.3.2 Biocon Description and Business Overview
11.3.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Biocon Insulin Drug and Delivery Technologies Products Offered
11.3.5 Biocon Related Developments
11.4 Julphar
11.4.1 Julphar Corporation Information
11.4.2 Julphar Description and Business Overview
11.4.3 Julphar Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Julphar Insulin Drug and Delivery Technologies Products Offered
11.4.5 Julphar Related Developments
11.5 Ypsomed
11.5.1 Ypsomed Corporation Information
11.5.2 Ypsomed Description and Business Overview
11.5.3 Ypsomed Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Ypsomed Insulin Drug and Delivery Technologies Products Offered
11.5.5 Ypsomed Related Developments
11.6 Becton, Dickinson and Company
11.6.1 Becton, Dickinson and Company Corporation Information
11.6.2 Becton, Dickinson and Company Description and Business Overview
11.6.3 Becton, Dickinson and Company Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Products Offered
11.6.5 Becton, Dickinson and Company Related Developments
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Insulin Drug and Delivery Technologies Products Offered
11.1.5 Sanofi Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Insulin Drug and Delivery Technologies Market Estimates and Projections by Region
12.1.1 Global Insulin Drug and Delivery Technologies Sales Forecast by Regions 2021-2026
12.1.2 Global Insulin Drug and Delivery Technologies Revenue Forecast by Regions 2021-2026
12.2 North America Insulin Drug and Delivery Technologies Market Size Forecast (2021-2026)
12.2.1 North America: Insulin Drug and Delivery Technologies Sales Forecast (2021-2026)
12.2.2 North America: Insulin Drug and Delivery Technologies Revenue Forecast (2021-2026)
12.2.3 North America: Insulin Drug and Delivery Technologies Market Size Forecast by Country (2021-2026)
12.3 Europe Insulin Drug and Delivery Technologies Market Size Forecast (2021-2026)
12.3.1 Europe: Insulin Drug and Delivery Technologies Sales Forecast (2021-2026)
12.3.2 Europe: Insulin Drug and Delivery Technologies Revenue Forecast (2021-2026)
12.3.3 Europe: Insulin Drug and Delivery Technologies Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Insulin Drug and Delivery Technologies Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Insulin Drug and Delivery Technologies Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Insulin Drug and Delivery Technologies Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Insulin Drug and Delivery Technologies Market Size Forecast by Region (2021-2026)
12.5 Latin America Insulin Drug and Delivery Technologies Market Size Forecast (2021-2026)
12.5.1 Latin America: Insulin Drug and Delivery Technologies Sales Forecast (2021-2026)
12.5.2 Latin America: Insulin Drug and Delivery Technologies Revenue Forecast (2021-2026)
12.5.3 Latin America: Insulin Drug and Delivery Technologies Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Insulin Drug and Delivery Technologies Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Insulin Drug and Delivery Technologies Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Insulin Drug and Delivery Technologies Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Insulin Drug and Delivery Technologies Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Insulin Drug and Delivery Technologies Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Insulin Drug and Delivery Technologies Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Insulin Drug and Delivery Technologies Market Segments
Table 2. Ranking of Global Top Insulin Drug and Delivery Technologies Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Insulin Drug and Delivery Technologies Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Insulin Syringes
Table 5. Major Manufacturers of Insulin Vials
Table 6. Major Manufacturers of Insulin Pens
Table 7. Major Manufacturers of Insulin Pumps
Table 8. Global Insulin Drug and Delivery Technologies Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Insulin Drug and Delivery Technologies Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Insulin Drug and Delivery Technologies Sales by Regions 2015-2020 (K MT)
Table 11. Global Insulin Drug and Delivery Technologies Sales Market Share by Regions (2015-2020)
Table 12. Global Insulin Drug and Delivery Technologies Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Insulin Drug and Delivery Technologies Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Insulin Drug and Delivery Technologies Sales Share by Manufacturers (2015-2020)
Table 15. Global Insulin Drug and Delivery Technologies Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Insulin Drug and Delivery Technologies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Drug and Delivery Technologies as of 2019)
Table 17. Insulin Drug and Delivery Technologies Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Insulin Drug and Delivery Technologies Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Insulin Drug and Delivery Technologies Price (2015-2020) (USD/MT)
Table 20. Insulin Drug and Delivery Technologies Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Insulin Drug and Delivery Technologies Product Type
Table 22. Date of International Manufacturers Enter into Insulin Drug and Delivery Technologies Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Insulin Drug and Delivery Technologies Sales by Type (2015-2020) (K MT)
Table 25. Global Insulin Drug and Delivery Technologies Sales Share by Type (2015-2020)
Table 26. Global Insulin Drug and Delivery Technologies Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Insulin Drug and Delivery Technologies Revenue Share by Type (2015-2020)
Table 28. Insulin Drug and Delivery Technologies Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Insulin Drug and Delivery Technologies Sales by Application (2015-2020) (K MT)
Table 30. Global Insulin Drug and Delivery Technologies Sales Share by Application (2015-2020)
Table 31. North America Insulin Drug and Delivery Technologies Sales by Country (2015-2020) (K MT)
Table 32. North America Insulin Drug and Delivery Technologies Sales Market Share by Country (2015-2020)
Table 33. North America Insulin Drug and Delivery Technologies Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Insulin Drug and Delivery Technologies Revenue Market Share by Country (2015-2020)
Table 35. North America Insulin Drug and Delivery Technologies Sales by Type (2015-2020) (K MT)
Table 36. North America Insulin Drug and Delivery Technologies Sales Market Share by Type (2015-2020)
Table 37. North America Insulin Drug and Delivery Technologies Sales by Application (2015-2020) (K MT)
Table 38. North America Insulin Drug and Delivery Technologies Sales Market Share by Application (2015-2020)
Table 39. Europe Insulin Drug and Delivery Technologies Sales by Country (2015-2020) (K MT)
Table 40. Europe Insulin Drug and Delivery Technologies Sales Market Share by Country (2015-2020)
Table 41. Europe Insulin Drug and Delivery Technologies Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Insulin Drug and Delivery Technologies Revenue Market Share by Country (2015-2020)
Table 43. Europe Insulin Drug and Delivery Technologies Sales by Type (2015-2020) (K MT)
Table 44. Europe Insulin Drug and Delivery Technologies Sales Market Share by Type (2015-2020)
Table 45. Europe Insulin Drug and Delivery Technologies Sales by Application (2015-2020) (K MT)
Table 46. Europe Insulin Drug and Delivery Technologies Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Insulin Drug and Delivery Technologies Sales by Region (2015-2020) (K MT)
Table 48. Asia Pacific Insulin Drug and Delivery Technologies Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Insulin Drug and Delivery Technologies Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Insulin Drug and Delivery Technologies Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Insulin Drug and Delivery Technologies Sales by Type (2015-2020) (K MT)
Table 52. Asia Pacific Insulin Drug and Delivery Technologies Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Insulin Drug and Delivery Technologies Sales by Application (2015-2020) (K MT)
Table 54. Asia Pacific Insulin Drug and Delivery Technologies Sales Market Share by Application (2015-2020)
Table 55. Latin America Insulin Drug and Delivery Technologies Sales by Country (2015-2020) (K MT)
Table 56. Latin America Insulin Drug and Delivery Technologies Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Insulin Drug and Delivery Technologies Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Insulin Drug and Delivery Technologies Revenue Market Share by Country (2015-2020)
Table 59. Latin America Insulin Drug and Delivery Technologies Sales by Type (2015-2020) (K MT)
Table 60. Latin America Insulin Drug and Delivery Technologies Sales Market Share by Type (2015-2020)
Table 61. Latin America Insulin Drug and Delivery Technologies Sales by Application (2015-2020) (K MT)
Table 62. Latin America Insulin Drug and Delivery Technologies Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Insulin Drug and Delivery Technologies Sales by Country (2015-2020) (K MT)
Table 64. Middle East and Africa Insulin Drug and Delivery Technologies Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Insulin Drug and Delivery Technologies Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Insulin Drug and Delivery Technologies Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Insulin Drug and Delivery Technologies Sales by Type (2015-2020) (K MT)
Table 68. Middle East and Africa Insulin Drug and Delivery Technologies Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Insulin Drug and Delivery Technologies Sales by Application (2015-2020) (K MT)
Table 70. Middle East and Africa Insulin Drug and Delivery Technologies Sales Market Share by Application (2015-2020)
Table 71. Sanofi Corporation Information
Table 72. Sanofi Description and Major Businesses
Table 73. Sanofi Insulin Drug and Delivery Technologies Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 74. Sanofi Product
Table 75. Sanofi Recent Development
Table 76. Eli Lilly and Company Corporation Information
Table 77. Eli Lilly and Company Description and Major Businesses
Table 78. Eli Lilly and Company Insulin Drug and Delivery Technologies Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Eli Lilly and Company Product
Table 80. Eli Lilly and Company Recent Development
Table 81. Biocon Corporation Information
Table 82. Biocon Description and Major Businesses
Table 83. Biocon Insulin Drug and Delivery Technologies Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Biocon Product
Table 85. Biocon Recent Development
Table 86. Julphar Corporation Information
Table 87. Julphar Description and Major Businesses
Table 88. Julphar Insulin Drug and Delivery Technologies Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Julphar Product
Table 90. Julphar Recent Development
Table 91. Ypsomed Corporation Information
Table 92. Ypsomed Description and Major Businesses
Table 93. Ypsomed Insulin Drug and Delivery Technologies Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Ypsomed Product
Table 95. Ypsomed Recent Development
Table 96. Becton, Dickinson and Company Corporation Information
Table 97. Becton, Dickinson and Company Description and Major Businesses
Table 98. Becton, Dickinson and Company Insulin Drug and Delivery Technologies Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Becton, Dickinson and Company Product
Table 100. Becton, Dickinson and Company Recent Development
Table 101. Global Insulin Drug and Delivery Technologies Sales Forecast by Regions (2021-2026) (K MT)
Table 102. Global Insulin Drug and Delivery Technologies Sales Market Share Forecast by Regions (2021-2026)
Table 103. Global Insulin Drug and Delivery Technologies Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 104. Global Insulin Drug and Delivery Technologies Revenue Market Share Forecast by Regions (2021-2026)
Table 105. North America: Insulin Drug and Delivery Technologies Sales Forecast by Country (2021-2026) (K MT)
Table 106. North America: Insulin Drug and Delivery Technologies Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Europe: Insulin Drug and Delivery Technologies Sales Forecast by Country (2021-2026) (K MT)
Table 108. Europe: Insulin Drug and Delivery Technologies Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Asia Pacific: Insulin Drug and Delivery Technologies Sales Forecast by Region (2021-2026) (K MT)
Table 110. Asia Pacific: Insulin Drug and Delivery Technologies Revenue Forecast by Region (2021-2026) (US$ Million)
Table 111. Latin America: Insulin Drug and Delivery Technologies Sales Forecast by Country (2021-2026) (K MT)
Table 112. Latin America: Insulin Drug and Delivery Technologies Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Middle East and Africa: Insulin Drug and Delivery Technologies Sales Forecast by Country (2021-2026) (K MT)
Table 114. Middle East and Africa: Insulin Drug and Delivery Technologies Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 116. Key Challenges
Table 117. Market Risks
Table 118. Main Points Interviewed from Key Insulin Drug and Delivery Technologies Players
Table 119. Insulin Drug and Delivery Technologies Customers List
Table 120. Insulin Drug and Delivery Technologies Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Drug and Delivery Technologies Product Picture
Figure 2. Global Insulin Drug and Delivery Technologies Sales Market Share by Type in 2020 & 2026
Figure 3. Insulin Syringes Product Picture
Figure 4. Insulin Vials Product Picture
Figure 5. Insulin Pens Product Picture
Figure 6. Insulin Pumps Product Picture
Figure 7. Global Insulin Drug and Delivery Technologies Sales Market Share by Application in 2020 & 2026
Figure 8. Diabetes Mellitus Type 1
Figure 9. Diabetes Mellitus Type 2
Figure 10. Gestational Diabetes
Figure 11. Insulin Drug and Delivery Technologies Report Years Considered
Figure 12. Global Insulin Drug and Delivery Technologies Market Size 2015-2026 (US$ Million)
Figure 13. Global Insulin Drug and Delivery Technologies Sales 2015-2026 (K MT)
Figure 14. Global Insulin Drug and Delivery Technologies Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Insulin Drug and Delivery Technologies Sales Market Share by Region (2015-2020)
Figure 16. Global Insulin Drug and Delivery Technologies Sales Market Share by Region in 2019
Figure 17. Global Insulin Drug and Delivery Technologies Revenue Market Share by Region (2015-2020)
Figure 18. Global Insulin Drug and Delivery Technologies Revenue Market Share by Region in 2019
Figure 19. Global Insulin Drug and Delivery Technologies Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Insulin Drug and Delivery Technologies Revenue in 2019
Figure 21. Insulin Drug and Delivery Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Insulin Drug and Delivery Technologies Sales Market Share by Type (2015-2020)
Figure 23. Global Insulin Drug and Delivery Technologies Sales Market Share by Type in 2019
Figure 24. Global Insulin Drug and Delivery Technologies Revenue Market Share by Type (2015-2020)
Figure 25. Global Insulin Drug and Delivery Technologies Revenue Market Share by Type in 2019
Figure 26. Global Insulin Drug and Delivery Technologies Market Share by Price Range (2015-2020)
Figure 27. Global Insulin Drug and Delivery Technologies Sales Market Share by Application (2015-2020)
Figure 28. Global Insulin Drug and Delivery Technologies Sales Market Share by Application in 2019
Figure 29. Global Insulin Drug and Delivery Technologies Revenue Market Share by Application (2015-2020)
Figure 30. Global Insulin Drug and Delivery Technologies Revenue Market Share by Application in 2019
Figure 31. North America Insulin Drug and Delivery Technologies Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Insulin Drug and Delivery Technologies Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Insulin Drug and Delivery Technologies Sales Market Share by Country in 2019
Figure 34. North America Insulin Drug and Delivery Technologies Revenue Market Share by Country in 2019
Figure 35. U.S. Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Insulin Drug and Delivery Technologies Market Share by Type in 2019
Figure 40. North America Insulin Drug and Delivery Technologies Market Share by Application in 2019
Figure 41. Europe Insulin Drug and Delivery Technologies Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Insulin Drug and Delivery Technologies Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Insulin Drug and Delivery Technologies Sales Market Share by Country in 2019
Figure 44. Europe Insulin Drug and Delivery Technologies Revenue Market Share by Country in 2019
Figure 45. Germany Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Insulin Drug and Delivery Technologies Market Share by Type in 2019
Figure 56. Europe Insulin Drug and Delivery Technologies Market Share by Application in 2019
Figure 57. Asia Pacific Insulin Drug and Delivery Technologies Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Insulin Drug and Delivery Technologies Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Insulin Drug and Delivery Technologies Sales Market Share by Region in 2019
Figure 60. Asia Pacific Insulin Drug and Delivery Technologies Revenue Market Share by Region in 2019
Figure 61. China Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Insulin Drug and Delivery Technologies Market Share by Type in 2019
Figure 84. Asia Pacific Insulin Drug and Delivery Technologies Market Share by Application in 2019
Figure 85. Latin America Insulin Drug and Delivery Technologies Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Insulin Drug and Delivery Technologies Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Insulin Drug and Delivery Technologies Sales Market Share by Country in 2019
Figure 88. Latin America Insulin Drug and Delivery Technologies Revenue Market Share by Country in 2019
Figure 89. Mexico Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Insulin Drug and Delivery Technologies Market Share by Type in 2019
Figure 96. Latin America Insulin Drug and Delivery Technologies Market Share by Application in 2019
Figure 97. Middle East and Africa Insulin Drug and Delivery Technologies Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Insulin Drug and Delivery Technologies Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Insulin Drug and Delivery Technologies Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Insulin Drug and Delivery Technologies Revenue Market Share by Country in 2019
Figure 101. Turkey Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Insulin Drug and Delivery Technologies Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Insulin Drug and Delivery Technologies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Insulin Drug and Delivery Technologies Market Share by Type in 2019
Figure 108. Middle East and Africa Insulin Drug and Delivery Technologies Market Share by Application in 2019
Figure 109. North America Insulin Drug and Delivery Technologies Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. North America Insulin Drug and Delivery Technologies Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Insulin Drug and Delivery Technologies Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Europe Insulin Drug and Delivery Technologies Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Insulin Drug and Delivery Technologies Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Asia Pacific Insulin Drug and Delivery Technologies Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Insulin Drug and Delivery Technologies Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Latin America Insulin Drug and Delivery Technologies Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Insulin Drug and Delivery Technologies Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Middle East and Africa Insulin Drug and Delivery Technologies Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
糖尿病治療・ドラッグデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Diabetes Therapy and Drug Delivery Market The global Diabetes Therapy and Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Diabetes Therapy and Drug Delivery Scope and …- CISインスリンの世界市場（～2026年） Insulin is a peptide hormone produced by beta cells of the pancreatic islets, which is considered to be the main anabolic hormone of the body. Russia is estimated to witness a significant growth over the next decade owing to the various subsidies provided by the local government. Market Analysis and…
- 次世代糖尿病治療・ドラッグデリバリーの世界市場（～2026年） Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level. The market growth is attributed to the rise in the number of diabetic patients globally …
- バイオシミラーインスリンの世界市場（～2026年） Biosimilars is a biological product designed to have similar active properties to the one that has been previously licensed and has no clinically significant differences in terms of safety and effectiveness. Biosimilars insulin is a type of biosimilars where it is indistinguishable to the reference …
- インスリンデテミルの世界市場（～2026年） Market Analysis and Insights: Global Insulin Detemir Market The global Insulin Detemir market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Insulin Detemir Scope and Market Size Insulin Detemir market is segmented by Type, …